406 related articles for article (PubMed ID: 17488966)
1. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.
Caviglia GP; Sciacca C; Abate ML; Olivero A; Rosso C; Touscoz GA; Ciancio A; Rizzetto M; Smedile A
J Gastroenterol Hepatol; 2015 Apr; 30(4):742-7. PubMed ID: 25351042
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C infection and risk of malignant lymphoma.
Schöllkopf C; Smedby KE; Hjalgrim H; Rostgaard K; Panum I; Vinner L; Chang ET; Glimelius B; Porwit A; Sundström C; Hansen M; Adami HO; Melbye M
Int J Cancer; 2008 Apr; 122(8):1885-90. PubMed ID: 18271005
[TBL] [Abstract][Full Text] [Related]
4. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
5. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative diseases and hepatitis C virus infection.
Hausfater P; Rosenthal E; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
[TBL] [Abstract][Full Text] [Related]
7. Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study.
Omland LH; Jepsen P; Krarup H; Christensen PB; Weis N; Nielsen L; Obel N; Sørensen HT; Stuver SO;
Int J Cancer; 2012 May; 130(10):2310-7. PubMed ID: 21780099
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
McGinnis KA; Fultz SL; Skanderson M; Conigliaro J; Bryant K; Justice AC
J Clin Oncol; 2006 Nov; 24(31):5005-9. PubMed ID: 17075119
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.
Stefanova-Petrova DV; Tzvetanska AH; Naumova EJ; Mihailova AP; Hadjiev EA; Dikova RP; Vukov MI; Tchernev KG
World J Gastroenterol; 2007 Dec; 13(48):6518-28. PubMed ID: 18161922
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France.
Hausfater P; Cacoub P; Sterkers Y; Thibault V; Amoura Z; Nguyen L; Ghillani P; Leblond V; Piette JC
Am J Hematol; 2001 Jul; 67(3):168-71. PubMed ID: 11391713
[TBL] [Abstract][Full Text] [Related]
11. HCV and lymphoproliferative diseases.
Trépo C; Berthillon P; Vitvitski L
Ann Oncol; 1998 May; 9(5):469-70. PubMed ID: 9653484
[No Abstract] [Full Text] [Related]
12. Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group.
Hausfater P; Cacoub P; Rosenthal E; Bernard N; Loustaud-Ratti V; Le Lostec Z; Laurichesse H; Turpin F; Ouzan D; Grasset D; Perrone C; Cabrol MP; Piette JC
Am J Hematol; 2000 Jun; 64(2):107-11. PubMed ID: 10814989
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and lymphoproliferative disorders: from mixed cryoglobulinemia to non-Hodgkin's lymphoma.
Martyak LA; Yeganeh M; Saab S
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):900-5. PubMed ID: 19362606
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies.
Dal Maso L; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2078-85. PubMed ID: 17119031
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
16. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection and lymphoproliferative disorders.
Peña LR; Nand S; De Maria N; Van Thiel DH
Dig Dis Sci; 2000 Sep; 45(9):1854-60. PubMed ID: 11052331
[No Abstract] [Full Text] [Related]
18. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.
Mahale P; Engels EA; Li R; Torres HA; Hwang LY; Brown EL; Kramer JR
Gut; 2018 Mar; 67(3):553-561. PubMed ID: 28634198
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.
Silvestri F; Barillari G; Fanin R; Zaja F; Infanti L; Patriarca F; Baccarani M; Pipan C; Falasca E; Botta GA
Blood; 1996 Aug; 88(3):1125-6. PubMed ID: 8704227
[No Abstract] [Full Text] [Related]
20. Hepatitis C virus infection in non-Hodgkin's lymphoma.
King PD; Wilkes JD; Diaz-Arias AA
Clin Lab Haematol; 1998 Apr; 20(2):107-10. PubMed ID: 9681221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
